17.11.2012 Views

Annual Report 2008 - IVA

Annual Report 2008 - IVA

Annual Report 2008 - IVA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>IVA</strong> South<br />

ivA south is a central node for the activities in southern sweden.<br />

in <strong>2008</strong> issues addressed by ivA south included innovation and<br />

the innovative climate, nanotechnology and human capital’s effects<br />

on a company’s brand equity. energy and materials technology<br />

were the focus of ivA west on a visit to the new öresundsverket<br />

power plant and the höganäs AB metal powders company.<br />

Is short-sightedness threatening the<br />

future of the Swedish manufacturing<br />

industry?<br />

globalisation,<br />

fund capital and<br />

internationalisation<br />

of ownership of<br />

swedish industry<br />

have fundamentally<br />

raised expectations<br />

of company boards<br />

and management.<br />

The risk of shortsightedness<br />

has increased. sustainable profitability<br />

requires constant renewal, but the question<br />

is if companies today can really make the<br />

long-term investments in radical innovations<br />

that will form the basis for the next generation<br />

of the swedish processing and manufacturing<br />

industry. have we got the right information,<br />

methods and tools to determine if we are<br />

investing enough in business renewal, or are<br />

there some unpleasant surprises in store?<br />

These questions were the topic of lively discussion<br />

when ivA’s chairman hans dalborg,<br />

mats qviberg of hq and others debated the<br />

issues at a meeting at ivA on 8 october.<br />

Venture capital and entrepreneurship<br />

in biotechnology<br />

Biotech companies<br />

need more than a<br />

promising idea to<br />

gain momentum<br />

to develop into<br />

listed companies;<br />

they also need<br />

long-term support<br />

from financial backers.<br />

development<br />

times are long and not all ideas become<br />

profitable products. it takes time to plough<br />

through the rules and regulations that often<br />

exist in biotech contexts. when the results<br />

are in, it is important to decide how to use<br />

them. license the technology or develop it<br />

yourself? generate revenues from your own<br />

production or through royalties from other<br />

companies?<br />

At a meeting held by division x: Biotechnology,<br />

on 16 september various examples<br />

were presented of how biotech companies<br />

can be developed and what sort of support<br />

they need from backers.<br />

33<br />

<strong>IVA</strong> West<br />

ivA west is the node for the activities in western sweden. nanotechnology,<br />

energy technology, design and innovation have all been<br />

on the agenda there; for example, when ivA west focused on<br />

electrical energy from the perspective of sweden and western<br />

sweden. infrastructure issues were also explored as they relate to<br />

western sweden.<br />

Common diseases give Sweden<br />

a unique opportunity to become a<br />

leading research nation<br />

Potential for preventive<br />

measures<br />

for both physiological<br />

and psychiatric<br />

diseases may<br />

increase drastically<br />

thanks to the<br />

lifegene project<br />

at karolinska<br />

institute. As this<br />

project combines national registration data<br />

with numerous clinical studies and research<br />

projects, scientists are hoping to be able to<br />

document how genetics and the environment<br />

impact the development of our most<br />

common diseases. The project, which aims<br />

to determine the causes of common diseases<br />

such as cancer and psychiatric illness,<br />

was presented at a meeting held by division<br />

vii: Basic and interdisciplinary engineering<br />

sciences, on 10 november.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!